Table 1.
Papers in the Special Issue Therapeutic Approaches to Vascular Cognitive Impairment.
| Authors | Title | Affiliation | Countries |
|---|---|---|---|
| Alsulaimani RA, TJ Quinn | The Efficacy and Safety of Animal-Derived Nootropics in cognitive disorders: Systematic Review and Meta-Analysis. | Abdul-Aziz University, Jeddah; University of Glasgow | Saudi Arabia, UK |
| Arshad F, S Mondal, A Paplikar, S Rajendran, Y Kalkonde, S Alladi | Treatment approaches for Vascular Cognitive Impairment in India | National Institute of Mental Health and Neurosciences, Bengaluru; Action & Research in Community Health, Gadchiroli | India |
| Bihaqi SW, HV Rao, A Sen, P Grammas | Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease | Ryan Inst for Neuroscience, University of Rhode Island; Thomas Jefferson University, Philadelphia; Rajendra Memorial Research Inst of Medical Sciences, Patna | USA, India |
| Blair GW, MS Stringer, MJ Thrippleton, FM Chappell, K Shuler, I Hamilton, DJ Garcia, FN Doubal, A Kopczak, M Duering, M Ingrisch, D Kerkhofs, J Staals, H van den Brink, T Arts, WH Backes, R van Oostenbrugge, GJ Biessels, M Dichgans, JM Wardlaw | Imaging NeuroVascular, Endothelial and STructural Integrity in prepAration to TrEat Small Vessel Diseases. The INVESTIGATE-SVDs study Protocol. Part of the SVDs@Target Project | University of Edinburgh; University Hospital, LMU Munich; Maastricht University; University Medical Center Utrecht; DZNE, Munich; SyNergy, Munich |
UK, The Netherlands, Germany |
| De Heus R, DLK De Jog, BL Lawlor, JAHR Claassen | Longitudinal changes in the control mechanisms for blood pressure and cerebral blood flow in Alzheimer's disease: secondary results of a randomized controlled trial | Radboud University Medical Center; Trinity College Dublin | The Netherlands, Ireland |
| Early F, EM Weekman, DM Wilcock | Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention. | University of Kentucky, Lexington | USA |
| Ihara M, K Washida, T Yoshimoto, S Saito | Adrenomedullin: a vasoactive agent for sporadic and hereditary vascular cognitive impairment | National Cerebral and Cardiovascular Center, Osaka | Japan |
| Leijenaar JF, S Ingala, CH Sudre, HJMM Mutsaerts, AE Leeuwis, WM van der Flier, P Scheltens, HC Weinstein, F Barkhof, J van Gerven, GJ Groeneveld, ND Prins | Differences between responders and non-responders to methylphenidate or galantamine in VCI | VU University Medical Center, Amsterdam; King's College London; Institute of Neurology, University College London; University Hospital Ghent; Onze Lieve Vrouwe Gasthuis West, Amsterdam; center for Human Drug Research, Leiden; Leiden University Medical Center | The Netherlands, UK, Belgium |
| Morrison E, DM Lyall, JP Pell, DF Mackay, FN Doubal, JM Wardlaw, TJ Quinn, SDJ Makin | Feasibility of trials of existing vascular prevention, as treatments for cerebrovascular small vessel disease in patients without symptomatic stroke. | University of Glasgow; University of Edinburgh; University of Aberdeen | UK |
| Wafford K | Aberrant waste disposal in neurodegeneration: why improved sleep could be the solution | Slowave Therapeutics Ltd, Guildford | UK |
| Wharton W, L Jeong, L Ni, AA Bay, RJ Shin, LE McCullough, H Silverstein, AR Hart, D Swieboda, W Hu, ME Hackney | A pilot randomized clinical trial of adapted tango to improve cognition and psychosocial function in african american women with family history of Alzheimer's disease (ACT trial) | Emory University, Atlanta; University of Georgia, Athens; Rutgers University; Birmingham/Atlanta VA Geriatric Research Clinical and Education Center | USA |
Papers are listed in alphabetical order of first author surname.